Live Market Updates
Latest Financial News
News Feed
1 articles
Personalized
Live Market Updates
Latest Financial News
positive
3h agoBrokerages turn bullish on Tata Consumer, Ambuja, and Blue Dart
Brokerage firm Motilal Oswal issued fresh buy ratings on several Indian companies, citing strong earnings visibility and favorable valuations. The report includes Tata Consumer Products, Niva Bupa, Gland Pharma, Blue Dart Express, Ambuja Cements, and Ajanta Pharma. Revised target prices reflect optimism around expanding consumption demand, healthcare growth, and logistics recovery. Analysts noted improving margins in FMCG and cement sectors, with tailwinds from rural revival and infrastructure projects. Investor sentiment in defensive stocks remains steady amid global market volatility.
positive
3h agoBrokerages turn bullish on Tata Consumer, Ambuja, and Blue Dart
Brokerage firm Motilal Oswal issued fresh buy ratings on several Indian companies, citing strong earnings visibility and favorable valuations. The report includes Tata Consumer Products, Niva Bupa, Gland Pharma, Blue Dart Express, Ambuja Cements, and Ajanta Pharma. Revised target prices reflect optimism around expanding consumption demand, healthcare growth, and logistics recovery. Analysts noted improving margins in FMCG and cement sectors, with tailwinds from rural revival and infrastructure projects. Investor sentiment in defensive stocks remains steady amid global market volatility.
Breaking
positive
Brokerages turn bullish on Tata Consumer, Ambuja, and Blue Dart
about 3 hours ago
1 min read
79 words
Motilal Oswal upgraded buy ratings for Tata Consumer, Ambuja Cements, and Blue Dart, highlighting growth visibility across FMCG, healthcare, and logistics amid improving domestic demand.
Brokerage firm Motilal Oswal issued fresh buy ratings on several Indian companies, citing strong earnings visibility and favorable valuations. The report includes Tata Consumer Products, Niva Bupa, Gland Pharma, Blue Dart Express, Ambuja Cements, and Ajanta Pharma. Revised target prices reflect optimism around expanding consumption demand, healthcare growth, and logistics recovery. Analysts noted improving margins in FMCG and cement sectors, with tailwinds from rural revival and infrastructure projects. Investor sentiment in defensive stocks remains steady amid global market volatility.
Brokerage firm Motilal Oswal issued fresh buy ratings on several Indian companies, citing strong earnings visibility and favorable valuations. The report includes Tata Consumer Products, Niva Bupa, Gland Pharma, Blue Dart Express, Ambuja Cements, and Ajanta Pharma. Revised target prices reflect optimism around expanding consumption demand, healthcare growth, and logistics recovery. Analysts noted improving margins in FMCG and cement sectors, with tailwinds from rural revival and infrastructure projects. Investor sentiment in defensive stocks remains steady amid global market volatility.
Companies:
Tata Consumer Products
Ambuja Cements
Blue Dart
+3 more
Tags:
stocks
brokerage
stocks
brokerage
recommendations
india
Nov 4, 2025 • 16:29 IST